An Investigation of the Effects of Riluzole in Patients With Post-Traumatic Stress Disorder (PTSD)

Trial Profile

An Investigation of the Effects of Riluzole in Patients With Post-Traumatic Stress Disorder (PTSD)

Recruiting
Phase of Trial: Phase I

Latest Information Update: 09 Feb 2017

At a glance

  • Drugs Riluzole (Primary)
  • Indications Post-traumatic stress disorders
  • Focus Therapeutic Use
  • Most Recent Events

    • 22 Apr 2016 Planned number of patients changed from 100 to 20.
    • 22 Apr 2016 Phase of the trial changed from phase II to phase I. Study design of the trial is changed to open label from double blind along with inclusion of geriatric patients. Accordingly changes in inclusion-exclusion criteria, age keywords. no of arms changed from 2 to 1 (removal of placebo arm).
    • 25 Aug 2014 Status changed from not yet recruiting to recruiting as reported by ClinicalTrial.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top